Home/ Supplements/ Omega 3/ Fish Oil 1500 +Krill

Fish Oil 1500 +Krill

product on market Softgel Capsule GNC Triple Strength Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Fish Oil 1500 +Krill
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Softgel Capsule(s)
Serving Size
30
Servings
Fat/Fatty Acid
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
20 {Calories}
Total Fat
2 Gram(s) (2% DV)
Fish Body Oil
1500 mg
Market median: 500.0mg (239 products)

Other Ingredients

Gelatin Glycerin Enteric Coating
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement, take two softgel capsules daily with food. Take every day as directed.

Warnings & Precautions

Discontinue use two weeks prior to surgery.

KEEP OUT OF REACH OF CHILDREN.

CONTAINS: Crustaceans (Krill).

WARNING: Consult your physician prior to using this product if you are pregnant, nursing, taking medication, or have a medical condition.

Formulation Notes

No Sugar, No Artificial Colors, No Artificial Flavors, No Wheat, No Gluten, No Corn, No Dairy, Yeast Free.

- 1500 mg of fish oil in each serving, providing 900 mg total omega-3 fatty acids EPA and DHA - 300 mg of Neptune Krill Oil(TM) with enhanced omega absorption

CONTAINS: Crustaceans (Krill).

Blended with 100% Pure Neptune Krill Oil.

Additional Information

Conforms to USP <2091> for weight.

Store in a cool, dry place.

- Clinically proven to promote joint and heart health - Provides enhanced antioxidant protection

5X CERTIFIED PURIFIED

CODE 887522 HOG

Metadata

Product Details

UPC / SKU0 48107 13391 7
DSLD Entry Date2014-08-26
Product TypeFat/Fatty Acid
FormSoftgel Capsule
DSLD ID36098
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.